fig2

Efficacy and safety of immune checkpoint therapy in hepatocellular carcinoma: meta-analysis

Figure 2. Objective response rate (ORR) of immune checkpoint inhibitor

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/